MedWatch

Ambu launches new gastroscope in Japan and Europe

Following approvals in the EU and Japan for a single-use gastroscope and a display unit, Ambu has announced the launches of both products on these markets.

Photo: Ambu PR

Having received both the CE mark in Europe and now also market clearance in Japan for the single-use gastroscope and display ecosystem, Ascope Gastro and Abox 2, the global product launch will be expanded to include Europe and Japan, Ambu has announced in a press release.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs